Concepedia

Vazganush Gharibyan

VG

12

Publications

1.8K

Citations

12

H-Index

2005

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Temple University

Vazganush Gharibyan is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, epigenetics, and epigenomics.

Top concepts

Publications per year

2005–2016

12

Publications

12

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome–negative CML, and megakaryocytic leukemia

Jaroslav Jelı́nek, Yasuhiro Oki, Vazganush Gharibyan et al. · Blood · 2005 · 370 citations · Full text

Phase II Study of Low-Dose Decitabine in Patients With Chronic Myelogenous Leukemia Resistant to Imatinib Mesylate

Jean‐Pierre J. Issa, Vazganush Gharibyan, Jörge E. Cortes et al. · Journal of Clinical Oncology · 2005 · 285 citations · Full text

LINE-1 Hypomethylation in Cancer Is Highly Variable and Inversely Correlated with Microsatellite Instability

Marcos R. Estecio, Vazganush Gharibyan, Lanlan Shen et al. · PLoS ONE · 2007 · 264 citations · Full text

Histone deacetylase inhibitor activity in royal jelly might facilitate caste switching in bees

Astrid Spannhoff, Yong Kee Kim, Noël J.‐M. Raynal et al. · EMBO Reports · 2011 · 205 citations · Full text

, , +5

Phase II study of low‐dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia

Yasuhiro Oki, Hagop M. Kantarjian, Vazganush Gharibyan et al. · Cancer · 2007 · 134 citations · Full text

Rows per page

1–5 of 12